251 related articles for article (PubMed ID: 29991926)
21. Serum plasminogen activator inhibitor-1 levels in patients with major depressive disorder vs. healthy controls: a systematic review and meta-analysis.
Elsayed M; Mohamed KA; Dardeer KT; Zaafar DK; Hassanin SO; Abdelnaby R; Schönfeldt-Lecuona C
Trends Psychiatry Psychother; 2023; 45():e20230338. PubMed ID: 34798692
[TBL] [Abstract][Full Text] [Related]
22. Circadian fluctuations of plasminogen activator inhibitor and tissue plasminogen activator levels in plasma of patients with unstable coronary artery disease and acute myocardial infarction.
Huber K; Rosc D; Resch I; Schuster E; Glogar DH; Kaindl F; Binder BR
Thromb Haemost; 1988 Dec; 60(3):372-6. PubMed ID: 3149044
[TBL] [Abstract][Full Text] [Related]
23. Plasminogen activator inhibitor-1 (PAI-1) 4G/5G promoter polymorphisms and risk of venous thromboembolism - a meta-analysis and systematic review.
Zhang Q; Jin Y; Li X; Peng X; Peng N; Song J; Xu M
Vasa; 2020 Mar; 49(2):141-146. PubMed ID: 31920171
[No Abstract] [Full Text] [Related]
24. Plasminogen Activator Inhibitor-1-Positive Platelet-Derived Extracellular Vesicles Predicts MACE and the Proinflammatory SMC Phenotype.
Jung RG; Duchez AC; Simard T; Dhaliwal S; Gillmore T; Di Santo P; Labinaz A; Ramirez FD; Rasheed A; Robichaud S; Ouimet M; Short S; Clifford C; Xiao F; Lordkipanidzé M; Burger D; Gadde S; Rayner KJ; Hibbert B
JACC Basic Transl Sci; 2022 Oct; 7(10):985-997. PubMed ID: 36337926
[TBL] [Abstract][Full Text] [Related]
25. Plasminogen activator inhibitor-1 and type 2 diabetes: a systematic review and meta-analysis of observational studies.
Yarmolinsky J; Bordin Barbieri N; Weinmann T; Ziegelmann PK; Duncan BB; Inês Schmidt M
Sci Rep; 2016 Jan; 6():17714. PubMed ID: 26813008
[TBL] [Abstract][Full Text] [Related]
26. Accelerated plasminogen activator inhibitor may prevent late restenosis after coronary stenting in acute myocardial infarction.
Inoue T; Yaguchi I; Mizoguchi K; Uchida T; Takayanagi K; Hayashi T; Morooka S; Eguchi Y
Clin Cardiol; 2003 Mar; 26(3):153-7. PubMed ID: 12685623
[TBL] [Abstract][Full Text] [Related]
27. High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor.
Thögersen AM; Jansson JH; Boman K; Nilsson TK; Weinehall L; Huhtasaari F; Hallmans G
Circulation; 1998 Nov; 98(21):2241-7. PubMed ID: 9826309
[TBL] [Abstract][Full Text] [Related]
28. Correlation between baseline plasminogen activator inhibitor levels and clinical outcome during therapy with tissue plasminogen activator for acute myocardial infarction.
Sane DC; Stump DC; Topol EJ; Sigmon KN; Kereiakes DJ; George BS; Mantell SJ; Macy E; Collen D; Califf RM
Thromb Haemost; 1991 Mar; 65(3):275-9. PubMed ID: 1904653
[TBL] [Abstract][Full Text] [Related]
29. [Meta-analysis on safety and efficacy of dual antiplatelet therapy combining with proton pump inhibitors for patients after percutaneous coronary intervention].
Che QQ; Wu Q; Liang YB; Sun RM; Lyu QW; Ma JL; Hu H; Lin X; Xu GL; Sun SG; Zhang C; Wang QY; Yu J; Bai F
Zhonghua Xin Xue Guan Bing Za Zhi; 2019 Feb; 47(2):129-140. PubMed ID: 30818941
[No Abstract] [Full Text] [Related]
30. Plasma and platelet plasminogen activator inhibitor-1 in patients with acute myocardial infarction.
Soeki T; Tamura Y; Fukuda N; Ito S
Jpn Circ J; 2000 Aug; 64(8):547-53. PubMed ID: 10952148
[TBL] [Abstract][Full Text] [Related]
31. The 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene is not associated with myocardial infarction.
Doggen CJ; Bertina RM; Cats VM; Reitsma PH; Rosendaal FR
Thromb Haemost; 1999 Jul; 82(1):115-20. PubMed ID: 10456464
[TBL] [Abstract][Full Text] [Related]
32. Tissue plasminogen activator, plasminogen activator inhibitor-1, and tissue plasminogen activator/plasminogen activator inhibitor-1 complex as risk factors for the development of a first stroke.
Johansson L; Jansson JH; Boman K; Nilsson TK; Stegmayr B; Hallmans G
Stroke; 2000 Jan; 31(1):26-32. PubMed ID: 10625711
[TBL] [Abstract][Full Text] [Related]
33. Angioplasty and stents in coronary artery disease: a systematic review and meta-analysis.
Dündar Y; Hill RA; Bakhai A; Dickson R; Walley T
Scand Cardiovasc J; 2004 Aug; 38(4):200-10. PubMed ID: 15553930
[TBL] [Abstract][Full Text] [Related]
34. Circulating levels of plasminogen activator inhibitor type-1, tissue plasminogen activator, and thrombomodulin in hemodialysis patients: biochemical correlations and role as independent predictors of coronary artery stenosis.
Segarra A; Chacón P; Martinez-Eyarre C; Argelaguer X; Vila J; Ruiz P; Fort J; Bartolomé J; Camps J; Moliner E; Pelegrí A; Marco F; Olmos A; Piera L
J Am Soc Nephrol; 2001 Jun; 12(6):1255-1263. PubMed ID: 11373350
[TBL] [Abstract][Full Text] [Related]
35. Causal Effect of Plasminogen Activator Inhibitor Type 1 on Coronary Heart Disease.
Song C; Burgess S; Eicher JD; O'Donnell CJ; Johnson AD
J Am Heart Assoc; 2017 May; 6(6):. PubMed ID: 28550093
[TBL] [Abstract][Full Text] [Related]
36. A decrease in plasminogen activator inhibitor-1 activity after successful percutaneous transluminal coronary angioplasty is associated with a significantly reduced risk for coronary restenosis.
Huber K; Jörg M; Probst P; Schuster E; Lang I; Kaindl F; Binder BR
Thromb Haemost; 1992 Feb; 67(2):209-13. PubMed ID: 1621240
[TBL] [Abstract][Full Text] [Related]
37. Plasminogen activator inhibitor type-1 (PAI-1) and its role in cardiovascular disease.
Nordt TK; Peter K; Ruef J; Kübler W; Bode C
Thromb Haemost; 1999 Sep; 82 Suppl 1():14-8. PubMed ID: 10695479
[TBL] [Abstract][Full Text] [Related]
38. Increased plasminogen activator inhibitor activity and diabetes predict subsequent coronary events in patients with angina pectoris.
Takazoe K; Ogawa H; Yasue H; Sakamoto T; Soejima H; Miyao Y; Kawano H; Moriyama Y; Misumi K; Suefuji H; Kugiyama K; Yoshimura M
Ann Med; 2001 Apr; 33(3):206-12. PubMed ID: 11370775
[TBL] [Abstract][Full Text] [Related]
39. Impaired fibrinolysis early after percutaneous transluminal coronary angioplasty is associated with restenosis.
Sakata K; Miura F; Sugino H; Shinobe M; Shirotani M; Yoshida H; Mori N; Hoshino T; Takada A
Am Heart J; 1996 Jan; 131(1):1-6. PubMed ID: 8553994
[TBL] [Abstract][Full Text] [Related]
40. Fibrinolytic parameters and insulin resistance in young survivors of myocardial infarction with heterozygous familial hypercholesterolemia.
Sebestjen M; Zegura B; Guzic-Salobir B; Keber I
Wien Klin Wochenschr; 2001 Feb; 113(3-4):113-8. PubMed ID: 11253736
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
